|
Price and Volume
Detailed Quote
Compare to:
|
Top News
More News
May 21 (Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for... Read More
category
companyNews
|